The market penetration rate of hydroxytyrosol is low and its application areas need to be expanded.

Hydroxytyrosol mainly exists in the form of the esterified product oleuropein in olive fruits, leaves and olive oil processing wastewater. In particular, the content of oleuropein and hydroxytyrosol in olive leaves is significantly higher than that in fruits and bark. Dried olive leaves account for about 6% to 9% (mass ratio). As a typical phenolic compound, hydroxytyrosol is considered to be one of the most efficient active antioxidants. It has strong antioxidant activity and pharmaceutical effects, so it is increasingly favored by the market.

Hydroxytyrosol has a variety of biological activities and has important applications in cosmetics, health products and drugs. However, due to the short time of promoting the use and industrialization of hydroxytyrosol in China, the demand scale is relatively small. In recent years, with the development of downstream fields such as cosmetics, medicines, and health products, as well as the increase in the penetration rate of hydroxytyrosol in the downstream market, the demand for hydroxytyrosol in China has shown a rapid growth trend. According to the“China Hydroxytyrosol Industry Market Monitoring and Future Development Prospects Research Report 2021-2025” released by the Industrial Research Center, In 2020, China’s demand for hydroxytyrosol is 42.92 tons, with a growth rate of 24.4%.

The hydroxytyrosol industry has relatively high barriers to entry in terms of technology, market, brand, talent, etc. In addition, China’s hydroxytyrosol industrial production technology research and put into use is relatively late, so the scale of industry development is small and the number of industry enterprises is not large. The companies include Shaanxi Senyuan Biotechnology Co., Ltd., Hangzhou Weibolai Biotechnology Co., Ltd., Shaanxi Fuheng Biotechnology Co., Ltd., Chengdu Jianteng Biotechnology Co., Ltd., Shanxi Yuning Biotechnology Co., Ltd., etc. Among them, Shaanxi Senyuan Biotechnology Co., Ltd. The company, Hangzhou Weibo Lai Biotechnology Co., Ltd., and Shaanxi Fuheng Biotechnology Co., Ltd. have larger production capacity and output. They are the leading companies in the domestic hydroxytyrosol industry and have a high market share.

Industry researchers said that at this stage, the penetration rate of hydroxytyrosol products in the downstream field is still low, and the scope of product application has yet to be further development. On the one hand, in the field of health products, with the continuous deepening of basic research and application exploration, people are becoming more and more aware of the nutrition, health care, disease prevention and other functions of nutrients such as hydroxytyrosol. At the same time, they benefit from the continuous improvement of application technology. Improvement, hydroxytyrosol will also be added to more health foods, such as health drinks, snack foods, meal replacement foods, etc. These health foods have consumer product attributes, and their rapid development will inevitably form more and more hydroxytyrosol. Raw material requirements.

On the other hand, in the field of medicine, hydroxytyrosol is antimicrobial, protects cardiovascular and nervous systems, improves metabolic syndrome, is anti-inflammatory, anti-tumor, and inhibits oxidative stress. However, its instability in the body results in short biological half-life and low bioavailability, which brings huge challenges to the application of hydroxytyrosol in the pharmaceutical field. Therefore, modifying hydroxytyrosol to obtain stable hydroxytyrosol derivatives to improve bioavailability, activity and efficacy is the direction of future efforts.